1. Optimal design, anti-tumour efficacy and tolerability of anti-CXCR4 antibody drug conjugates
    Maria José Costa et al, 2019, Scientific Reports CrossRef
  2. Impact of Cancer Stem Cells and Cancer Stem Cell-Driven Drug Resiliency in Lung Tumor: Options in Sight
    Lourdes Cortes-Dericks et al, 2022, Cancers CrossRef
  3. Clinical relevance of stem cells in lung cancer
    Horacio Eduardo Romeo et al, 2023, World Journal of Stem Cells CrossRef
  4. Lung cancer stem cells and their aggressive progeny, controlled by EGFR/MIG6 inverse expression, dictate a novel NSCLC treatment approach
    Zhiguang Xiao et al, 2019, Oncotarget CrossRef
  5. Elevated Expression of the RAGE Variant-V in SCLC Mitigates the Effect of Chemotherapeutic Drugs
    Bindhu K. Madhavan et al, 2021, Cancers CrossRef
  6. Lung Cancer Stem Cell Markers as Therapeutic Targets: An Update on Signaling Pathways and Therapies
    Yue Zheng et al, 2022, Frontiers in Oncology CrossRef
  7. Modulation of Immune Components on Stem Cell and Dormancy in Cancer
    Xiaofan Jiang et al, 2021, Cells CrossRef
  8. Properties of cancer stem cells
    Jacek Wojcierowski et al, 2022, Diagnostyka Laboratoryjna CrossRef
  9. CD44+/EPCAM+ cells detect a subpopulation of ALDHhigh cells in human non-small cell lung cancer: A chance for targeting cancer stem cells?
    Valentina Masciale et al, 2020, Oncotarget CrossRef
  10. Cancer Stem Cells (CSCs), Circulating Tumor Cells (CTCs) and Their Interplay with Cancer Associated Fibroblasts (CAFs): A New World of Targets and Treatments
    Beatrice Aramini et al, 2022, Cancers CrossRef
  11. EpCAM-positive disseminated cancer cells in bone marrow impact on survival of early-stage NSCLC patients
    Tobias Mederer et al, 2022, Lung Cancer CrossRef
  12. UBE2C is a Potential Biomarker for Tumorigenesis and Prognosis in Tongue Squamous Cell Carcinoma
    Pei-Feng Liu et al, 2020, Diagnostics CrossRef
  13. Novel Primary Human Cancer Stem-Like Cell Populations from Non-Small Cell Lung Cancer: Inhibition of Cell Survival by Targeting NF-κB and MYC Signaling
    Beatrice A. Windmöller et al, 2021, Cells CrossRef
  14. Transcriptome Analysis Identifies ALCAM Overexpression as a Prognosis Biomarker in Laryngeal Squamous Cell Carcinoma
    Pedro Nicolau-Neto et al, 2020, Cancers CrossRef
  15. Cancer Stem Cells—Origins and Biomarkers: Perspectives for Targeted Personalized Therapies
    Lia Walcher et al, 2020, Frontiers in Immunology CrossRef
  16. Breaking the niche: multidimensional nanotherapeutics for tumor microenvironment modulation
    K. Laxmi Swetha et al, 2023, Drug Delivery and Translational Research CrossRef
  17. Cancer Stem Cells
    Mridul Sharma et al, 2023, Handbook of Oncobiology: From Basic to Clinical Sciences CrossRef
  18. Cancer stem cells and macrophages: molecular connections and future perspectives against cancer
    Beatrice Aramini et al, 2021, Oncotarget CrossRef